Compare FINW & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FINW | AIRS |
|---|---|---|
| Founded | 1999 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.1M | 182.4M |
| IPO Year | 2021 | 2021 |
| Metric | FINW | AIRS |
|---|---|---|
| Price | $10.81 | $1.26 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $16.33 | $4.50 |
| AVG Volume (30 Days) | 31.9K | ★ 822.7K |
| Earning Date | 10-28-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.51 | N/A |
| EPS | ★ 0.35 | N/A |
| Revenue | N/A | ★ $151,818,000.00 |
| Revenue This Year | $41.06 | N/A |
| Revenue Next Year | $15.47 | $2.65 |
| P/E Ratio | $30.71 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.64 | $1.38 |
| 52 Week High | $19.86 | $12.00 |
| Indicator | FINW | AIRS |
|---|---|---|
| Relative Strength Index (RSI) | 23.29 | 22.98 |
| Support Level | N/A | N/A |
| Resistance Level | $14.55 | $3.31 |
| Average True Range (ATR) | 0.29 | 0.14 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 28.72 | 0.65 |
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and commercial customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.